Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Am J Obstet Gynecol. 2020 Feb 20;223(2):234.e1–234.e8. doi: 10.1016/j.ajog.2020.02.008

Table 2B.

Surgical demographics of women undergoing CPC vs. ERAS in minimally invasive non-hysterectomy procedures

Surgery Type* CPC
(n = 214)
ERAS
(n = 196)
Adnexal/Tubal 75 (35.0) 62 (31.6)
Endometriosis + Adnexal PSN 26 (12.2) 34 (17.4)
Endometriosis PSN 78 (36.5) 64 (32.7)
Endometriosis + Bowel Adnexal PSN 8 (3.7) 3 (1.5)
Myomectomy 9 (4.2) 20 (10.2)
Other 18 (8.4) 13 (6.6)

CPC, conventional peri-operative care; ERAS, enhanced recovery after surgery; PSN, presacral neurectomy

Data are n (%)

*

P-value .073; noting no difference in distribution between CPC and ERAS across any surgery types